DrugPatentWatch Database Preview
Try a free trialSee Plans and Pricing
« Back to Dashboard
The generic ingredient in SLYND is drospirenone. There are eleven drug master file entries for this compound. Additional details are available on the drospirenone profile page.
Generic Entry Opportunity Date for 211367
Generic Entry Date for 211367*:
Constraining patent/regulatory exclusivity:
*The generic entry opportunity date is the latter of the last compound-claiming patent and the last regulatory exclusivity protection. Many factors can influence early or later generic entry. This date is provided as a rough estimate of generic entry potential and should not be used as an independent source.
Pharmacology for NDA: 211367
Profile for product number 001
|Approval Date:||May 23, 2019||TE:||RLD:||Yes|
|Regulatory Exclusivity Expiration:||May 23, 2022|
|Regulatory Exclusivity Use:||NEW PRODUCT|
Complete Access Available with Subscription